Biocure Technology Inc (CURE.CX)
0.015
0.00 (0.00%)
CAD |
CNSX |
Apr 30, 16:00
Biocure Technology Max Drawdown (5Y): 99.70% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
April 30, 2024 | 99.70% |
March 31, 2024 | 99.70% |
February 29, 2024 | 99.70% |
January 31, 2024 | 99.70% |
December 31, 2023 | 99.70% |
November 30, 2023 | 99.70% |
October 31, 2023 | 99.70% |
September 30, 2023 | 99.70% |
August 31, 2023 | 99.70% |
July 31, 2023 | 99.70% |
June 30, 2023 | 99.70% |
May 31, 2023 | 99.70% |
April 30, 2023 | 99.70% |
March 31, 2023 | 99.70% |
February 28, 2023 | 99.70% |
January 31, 2023 | 99.70% |
December 31, 2022 | 99.70% |
November 30, 2022 | 99.70% |
October 31, 2022 | 97.87% |
September 30, 2022 | 97.87% |
August 31, 2022 | 97.87% |
July 31, 2022 | 97.87% |
June 30, 2022 | 97.26% |
May 31, 2022 | 97.26% |
April 30, 2022 | 97.26% |
Date | Value |
---|---|
March 31, 2022 | 97.26% |
February 28, 2022 | 96.34% |
January 31, 2022 | 94.51% |
December 31, 2021 | 94.51% |
November 30, 2021 | 94.51% |
October 31, 2021 | 94.51% |
September 30, 2021 | 94.51% |
August 31, 2021 | 94.51% |
July 31, 2021 | 94.51% |
June 30, 2021 | 94.51% |
May 31, 2021 | 94.51% |
April 30, 2021 | 94.51% |
March 31, 2021 | 94.51% |
February 28, 2021 | 94.51% |
January 31, 2021 | 94.51% |
December 31, 2020 | 94.51% |
November 30, 2020 | 93.90% |
October 31, 2020 | 90.85% |
September 30, 2020 | 89.63% |
August 31, 2020 | 89.63% |
July 31, 2020 | 89.63% |
June 30, 2020 | 89.63% |
May 31, 2020 | 89.63% |
April 30, 2020 | 88.41% |
March 31, 2020 | 88.41% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
81.71%
Minimum
May 2019
99.70%
Maximum
Nov 2022
94.56%
Average
94.51%
Median
Dec 2020
Max Drawdown (5Y) Benchmarks
Core One Labs Inc | 99.78% |
Nova Mentis Life Science Corp | 99.28% |
Nanosphere Health Sciences Inc | 99.95% |
Lobe Sciences Ltd | -- |
Algernon Pharmaceuticals Inc | 99.52% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | -70.16 |
Beta (5Y) | 2.904 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 287.3% |
Historical Sharpe Ratio (5Y) | -0.1738 |
Historical Sortino (5Y) | -0.8731 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 42.86% |